General Information of the Compound
| Compound ID |
CP0432923
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(E)-4-[4-[[4-hydroxy-2-propan-2-yl-5-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]phenyl]methyl]-3-methylphenyl]-2,2-dimethyl-N-[2-methyl-1-(4-methylpiperazin-1-yl)-1-oxopropan-2-yl]but-3-enamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C38H55N3O8
|
||||||||||||||||||
| Molecular Weight |
681.871
|
||||||||||||||||||
| Canonical SMILES |
CC(C)c1cc(O)c(cc1Cc1ccc(\C=C\C(C)(C)C(=O)NC(C)(C)C(=O)N2CCN(C)CC2)cc1C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C38H55N3O8/c1-22(2)27-20-29(43)28(34-33(46)32(45)31(44)30(21-42)49-34)19-26(27)18-25-10-9-24(17-23(25)3)11-12-37(4,5)35(47)39-38(6,7)36(48)41-15-13-40(8)14-16-41/h9-12,17,19-20,22,30-34,42-46H,13-16,18,21H2,1-8H3,(H,39,47)/b12-11+/t30-,31-,32+,33-,34+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
RMBOTJRAGDPPOL-ZGMHKKTQSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03804, Sodium/glucose cotransporter 1
Protein ID: PT02415, Sodium/glucose cotransporter 2